Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Rivaroxaban thromboprophylaxis in ambulatory patients with pancreatic cancer: Results from a pre-specified subgroup analysis of the randomized CASSINI study.
Journal: Cancer medicine
Published: February 07, 2020
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.
Journal: The New England journal of medicine
Published: February 21, 2019
Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer.
Journal: Journal of blood medicine
Published: December 22, 2017
Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial. Rationale and Design of the CASSINI Trial.
Journal: Thrombosis and haemostasis
Published: September 22, 2017
Early Evidence of Cardiotoxicity and Tumor Response in Patients with Sarcomas after High Cumulative Dose Doxorubicin Given as a Continuous Infusion.
Journal: Sarcoma
Published: June 16, 2017
A multicenter case registry study on medication-related osteonecrosis of the jaw in patients with advanced cancer.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: December 28, 2016
A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia.
Journal: Journal of hematology & oncology
Published: December 06, 2016
Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study.
Journal: American journal of hematology
Published: November 04, 2015
Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 14, 2015
ABO non-O type as a risk factor for thrombosis in patients with pancreatic cancer.
Journal: Cancer medicine
Published: June 08, 2015
Evaluating results from the multiple myeloma patient subset treated with denosumab or zoledronic acid in a randomized phase 3 trial.
Journal: Blood cancer journal
Published: April 14, 2015
The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 19, 2015
Last Updated: 09/26/2026